Abstract
The treatment of Alzheimers disease is undoubtedly one of the greatest challenges of modern medicine and pharmacology. Affecting millions of people, Alzheimers disease has become a major social problem. Several theories have been proposed to account for its pathogenesis. Possibly, the “amyloid cascade hypothesis” is the dominant one. However, the “inflammation hypothesis” also contributes to the pathogenesis of the disease. Thus, this study intends to describe the role of neuroinflammation in Alzheimers disease, regarding its cellular and molecular components, and to examine if the use of non-steroidal anti-inflammatory drugs could be an effective “weapon” in the battle against it.
Keywords: Alzheimer's disease, inflammation, pharmacology, non-steroidal anti-inflammatory drugs, NSAIDs, APP, presenilin-1, presenilin-2, apolipoprotein E, APOE, Pen2, ubiquitin-proteasome pathway, clearance, Neuroinflammation, CD36, TLR4, synaptic plasticity, cyclooxygenase, COX, EP1-4, chlamydophila, helicobacter pylori, borrelia burgdorferi, Tg2576, R-flurbiprofen, ibuprofen, indomethacin, naproxen, flurbiprofen, CHF5022, CHF5074, ADAPT, MCI
CNS & Neurological Disorders - Drug Targets
Title: Non-Cholinergic Pharmacotherapy Approaches to Alzheimers Disease: The Use of Non-Steroidal Anti-Inflammatory Drugs
Volume: 10 Issue: 1
Author(s): S. Tsartsalis, P. K. Panagopoulos and M. Mironidou-Tzouveleki
Affiliation:
Keywords: Alzheimer's disease, inflammation, pharmacology, non-steroidal anti-inflammatory drugs, NSAIDs, APP, presenilin-1, presenilin-2, apolipoprotein E, APOE, Pen2, ubiquitin-proteasome pathway, clearance, Neuroinflammation, CD36, TLR4, synaptic plasticity, cyclooxygenase, COX, EP1-4, chlamydophila, helicobacter pylori, borrelia burgdorferi, Tg2576, R-flurbiprofen, ibuprofen, indomethacin, naproxen, flurbiprofen, CHF5022, CHF5074, ADAPT, MCI
Abstract: The treatment of Alzheimers disease is undoubtedly one of the greatest challenges of modern medicine and pharmacology. Affecting millions of people, Alzheimers disease has become a major social problem. Several theories have been proposed to account for its pathogenesis. Possibly, the “amyloid cascade hypothesis” is the dominant one. However, the “inflammation hypothesis” also contributes to the pathogenesis of the disease. Thus, this study intends to describe the role of neuroinflammation in Alzheimers disease, regarding its cellular and molecular components, and to examine if the use of non-steroidal anti-inflammatory drugs could be an effective “weapon” in the battle against it.
Export Options
About this article
Cite this article as:
Tsartsalis S., K. Panagopoulos P. and Mironidou-Tzouveleki M., Non-Cholinergic Pharmacotherapy Approaches to Alzheimers Disease: The Use of Non-Steroidal Anti-Inflammatory Drugs, CNS & Neurological Disorders - Drug Targets 2011; 10 (1) . https://dx.doi.org/10.2174/187152711794488629
DOI https://dx.doi.org/10.2174/187152711794488629 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Advances in the Treatment of Alzheimer's Disease: Present and Future
Current Drug Therapy Targeting Vascular Endothelial Growth Factor in Neuroblastoma
Current Angiogenesis (Discontinued) DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics Aurora Kinase Inhibitors in Head and Neck Cancer
Current Topics in Medicinal Chemistry Ion Channel Screening Technology
CNS & Neurological Disorders - Drug Targets Endostatin: Preclinical Development as an Anticancer Agent
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells
Current Drug Delivery Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
Current Gene Therapy Pharmacological Targets for the Inhibition of Neurogenic Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders
Current Pharmaceutical Biotechnology Ionic Liquids, Microextraction Methods and Capillary Electrophoresis in Biomedical Research
Current Pharmaceutical Analysis Erythropoietin: New Approaches to Improved Molecular Designs and Therapeutic Alternatives
Current Pharmaceutical Design Neuroprotective Effects of Nonsteroidal Anti-inflammatory Drugs on Neurodegenerative Diseases
Current Pharmaceutical Design Hypericin - The Facts About a Controversial Agent
Current Pharmaceutical Design Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats
Current Reviews in Clinical and Experimental Pharmacology Cellular Targets for Anticancer Strategies
Current Drug Targets The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Current Neuropharmacology Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science